Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Recombinant adenovirus serotype 5 (rAd5) vector-based vaccines are currently being developed for both human immunodeficiency virus type 1 and other pathogens. The potential limitations associated with rAd5 vectors, however, have led to the construction of novel rAd vectors derived from rare Ad serot...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Abbink, Peter, Lemckert, Angelique A. C., Ewald, Bonnie A., Lynch, Diana M., Denholtz, Matthew, Smits, Shirley, Holterman, Lennart, Damen, Irma, Vogels, Ronald, Thorner, Anna R., O'Brien, Kara L., Carville, Angela, Mansfield, Keith G., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology 2007
विषय:
Vaccines and Antiviral Agents
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900173/
https://ncbi.nlm.nih.gov/pubmed/17329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02696-06
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन